MEI Pharma, Inc.
MEI Pharma, Inc. (MEIP) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MEIP · as of Jun 9, 2026
Key Statistics
Explore MEI Pharma, Inc. Data
meip stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 18 · Buy rate: 55.6%
Competitors & Peers
meip competitorsMEIP
CSCI
DOMH
ELEV
KA
LSBStock Performance
Full HistoryAbout MEI Pharma, Inc.
MEI Pharma, Inc. is a late-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for various cancers. Its robust pipeline features seve…
what is mei pharma, inc. · meip stock overview · mei pharma, inc. company profile · who is mei pharma, inc. ceo · meip NASDAQ · mei pharma, inc. headquarters · mei pharma, inc. business segments
About Stock Overview & Key Data
MEI Pharma, Inc. (MEIP) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 18, 2003. As of the latest trading session, MEIP stock price is $3.07, with a market capitalization of $20.5M. The stock has returned +13.70% over the past 12 months and +20.39% year-to-date.
According to 18 Wall Street analysts, the consensus rating for MEI Pharma, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, MEI Pharma, Inc. reported revenue of — and net income of -$15.9M. For detailed data — including MEI Pharma, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, MEI Pharma, Inc. (MEIP) stock price is $3.07. The stock is traded on NASDAQ under the ticker symbol MEIP. The 52-week range is $1.46 – $9.00.